Orchestra BioMed
OBIO
OBIO
48 hedge funds and large institutions have $97.8M invested in Orchestra BioMed in 2024 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 21 increasing their positions, 10 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
more funds holding
Funds holding: →
16% less capital invested
Capital invested by funds: $116M → $97.8M (-$18.1M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
48
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$16.9M | |
| 2 | +$13.4M | |
| 3 | +$573K | |
| 4 |
BlackRock
New York
|
+$506K |
| 5 |
State Street
Boston,
Massachusetts
|
+$309K |
Top Sellers
| 1 | -$1.04M | |
| 2 | -$262K | |
| 3 | -$162K | |
| 4 |
Bank of New York Mellon
New York
|
-$119K |
| 5 |
IIA
IPG Investment Advisors
San Diego,
California
|
-$108K |